¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ±Û¾²±â ¼öÁ¤ »èÁ¦

ÀÎõ°ú¹Î¼º¹æ±¤ ÇÑÀÇ¿ø ÁÖ¸»Áø·á

ÃßõÇϱâ
ÇÑÀÇ¿ø À̹øÁÖ BEST
 

#ÀÎõ°ú¹Î¼º¹æ±¤, #ÀÎõ°ú¹Î¼º¹æ±¤ÇÑÀÇ¿ø, #¹æ±¤¿°, #ÀÎõ¹æ±¤¿°, #°ú¹Î¼º¹æ±¤ÇÑÀÇ¿ø, #¹æ±¤¿°ÇÑÀÇ¿ø, #ÀÎõ¹æ±¤¿°, #±¸¿ùµ¿°ú¹Î¼º¹æ±¤ 

 

 

ÀÎõ°ú¹Î¼º¹æ±¤,,ÀÎõ°ú¹Î¼º¹æ±¤ÇÑÀÇ¿ø,,¹æ±¤¿°,,ÀÎõ¹æ±¤¿°,,°ú¹Î¼º¹æ±¤ÇÑÀÇ¿ø,,¹æ±¤¿°ÇÑÀÇ¿ø,,ÀÎõ¹æ±¤¿°,,±¸¿ùµ¿°ú¹Î¼º¹æ±¤

¾È³çÇϼ¼¿ä. ÀÎõ°ú¹Î¼º¹æ±¤ ±¸¿ùµ¿ ÇÑÀÇ¿ø ãÀ¸½Ã´Â ºÐµéÀÌ ¸¹À¸½Åµ¥¿ä

 

 

ÀÎõ°ú¹Î¼º¹æ±¤ ±¸¿ùµ¿ Ä¡·á ãÀ¸½Ã´Â ºÐµéÀÌ ¹Ì¿ÃÇÑÀÇ¿ø ÀÎõÁ¡À» ÀÚÁÖ Ã£À¸½Ã´Âµ¥¿ä. ¹Ì¿ÃÇÑÀÇ¿ø¿¡´Â¹æ±¤¿°, °£Áú¼º¹æ±¤, ¼ºÀξߴ¢Áõ, ¹æ±¤¿°Ä¡·á, ¾ß´¢Áõ, ÀÜ´¢°¨, ¿©Àڹ汤¿°Áõ»ó, °£Áú¼º¹æ±¤¿°, ³²ÀÚÀÜ´¢°¨, ºÓÀº¼Òº¯, ¿©¼ºÀÜ´¢°¨, ¼Òº¯Ç÷´¢, ³²Àڹ汤¿°, Áú¿°ÀÜ´¢°¨, ¾î¸°ÀÌ¿ÀÁܼÒÅÂ, ÀÓ½ÅÁß¿ÀÁܼÒÅÂ, ¿ä½Ç±Ý, ¼Ò¾Æ¹æ±¤¿°, Àý¹Ú´¢, °ú¹Î¼º¹æ±¤, ¿©Àڹ财Åë, ºó´¢, Àü¸³¼±, ¹æ±¤¿°¼Òº¯, ¸¸¼º¹æ±¤¿°µî ´Ù¾çÇÑ ¹®ÀǸ¦ ÁÖ°í °è½Ê´Ï´Ù.

 

 

¹Ì¿ÃÇÑÀÇ¿ø¿¡´Â ´Ù¾çÇÑ È¯ÀںеéÀÌ ³»¿øÇÏ°í °è½Ã¸ç °³Àκ° Áõ»ó°ú üÁú¿¡ µû¶ó Àδ밭ȭ, ¼ÒÇÕÇâ¿ø, ¿Â¿­Ä¡·á, ¸¶»çÁö, ±ÙÀ̿Ͼàħ, ¾îÇ÷¾àħ, ¸Å¼±¿ä¹ý, µµÀο¿ä¹ý, ÁßdzÁ¶±â°ËÁø, Çâ±â¿ä¹ý, ´Ü¼ø¿îµ¿Ä¡·á, ½½¸µ, ·Ñ¸µ, ³Ã¿Â¿å, mechanical therapy, paraffin, Àü±âÀÚ±ØÄ¡·á, Çdz»Ä§, ü¿­Áø´Ü±â, ¾Æ·Î¸¶Å׶óÇÇ, ¸ÂÃãÇÑ¾à µî ÇÕ¸®ÀûÀÌ°í È¿°úÀûÀÎ ¸ÂÃã Ä¡·á¸¦ Á¦°øÇÏ°í ÀÖ½À´Ï´Ù

 

 

¹Ì¿ÃÇÑÀÇ¿øÀº Àü±¹ 20¿©°³ ÁöÁ¡¿¡¼­ Áø·áÁßÀÌ¸ç ºÎ»ê »çÇϱ¸ ´Ù´ë1µ¿, Àü³² ¿©¼ö½Ã °øÈ­µ¿, ¿ï»ê ºÏ±¸ »êÇϵ¿, Àü³² ±¸·Ê±º ±¤ÀǸé, °æ³² ÀǷɱº Ä¥°î¸é, ÀüºÏ ÀÍ»ê½Ã ÆȺÀµ¿, ÀÎõ °è¾ç±¸ µ¿¾çµ¿, ºÎ»ê ±ÝÁ¤±¸ ȸµ¿µ¿, °æ±â ¾È¼º½Ã ¼­Àε¿, °æ³² ±èÇؽà ¾î¹æµ¿, °æ³² â¿ø½Ã ¸¶»êÇÕÆ÷±¸ »ó³²µ¿, ºÎ»ê ¿µµµ±¸ ¿µ¼±µ¿3°¡, ÃæºÏ ÃæÁֽà ÁÖ´öÀ¾, °æºÏ ¹®°æ½Ã »ê¾ç¸é, Àü³² ¸ñÆ÷½Ã ÃøÈĵ¿, °æ³² °ÅÁ¦½Ã °ÅÁ¦¸é, ¿ï»ê Áß±¸ ¿Á±³µ¿, °­¿ø °­¸ª½Ã ȸ»êµ¿, Àü³² ¸ñÆ÷½Ã Ãູµ¿1°¡, °æ±â ¾È¼º½Ã ±Ý¼®µ¿, ºÎ»ê ºÏ±¸ È­¸íµ¿, Àü³² ³ªÁֽà »ï¿µµ¿, °æ³² â¿ø½Ã ¸¶»êÇÕÆ÷±¸ ¼ºÈ£µ¿, °­¿ø ö¿ø±º ±Ù³²¸é, °æ±â ¾È¾ç½Ã ¸¸¾È±¸ ¼®¼ö3µ¿, Àü³² ¿µ±¤±º ´ë¸¶¸é, °æ³² »çõ½Ã À̱ݵ¿, ÀüºÏ ÀüÁֽà ¿Ï»ê±¸ »ïõµ¿2°¡, ¿ï»ê ºÏ±¸ ´Þõµ¿, ÀÎõ °­È­±º ¾ç»ç¸é, µî ´Ù¾çÇÑ Áö¿ª Áֹε鲲¼­ ³»¿øÇÏ°í °è½Ê´Ï´Ù

 

 

ÀÎõ°ú¹Î¼º¹æ±¤Ä¡·á ãÀ¸½Ã´Â ÀÎõ³íÇöµ¿, ¹è°ð½Åµµ½Ã, ûÇе¿, ¿ëÇöµ¿, µ¿ÀÎõ, ¼þÀǵ¿, À²¸ñµ¿, °è¾ç±¸, ¿ëÀ¯µµ, °¡Á¤µ¿, °£¼®µ¿, ³íÇö°íÀܵ¿, ¼Û¸²µ¿, ºÎõ, µ¿±¸, Áßµ¿, °ü±³µ¿, Á־ȿª, °Ë¾Ï, ¿µÁ¾Çϴõµ½Ã, ¼Ò·¡Æ÷±¸, ³²µ¿±¸, °¡Áµ¿, ºñºÀ¸é, µµ¸²µ¿, ÀÎõÁÖ¾È, ³²¾çÀ¾, ¹®Çе¿, ÀÎõ, ¼±Çе¿, ÀÎõ³íÇö, ¹è°ð, ±¸¿ùµ¿, ¼Ûµµ±¹Á¦µµ½Ã, Áß±¸ µî ÀÎõ Áö¿ª Áֹε鲲¼­ ¹Ì¿ÃÇÑÀÇ¿øÀÎõÁ¡À» ¹æ¹®ÇÏ°í °è½Ê´Ï´Ù.

 

´õ »ìÆ캸±â

 

1. Gammie A, Kaper M, Dorrepaal C, et al. Signs and Symptoms of Detrusor Underactivity: An Analysis of Clinical Presentation and Urodynamic Tests From a Large Group of Patients Undergoing Pressure Flow Studies. Eur Urol 2016; 69:361.

2. Herzog AR, Diokno AC, Brown MB, et al. Urinary incontinence as a risk factor for mortality. J Am Geriatr Soc 1994; 42:264.

3. Minassian VA, Bazi T, Stewart WF. Clinical epidemiological insights into urinary incontinence. Int Urogynecol J 2017; 28:687.

4. Brown JS, Nyberg LM, Kusek JW, et al. Proceedings of the National Institute of Diabetes and Digestive and Kidney Diseases International Symposium on Epidemiologic Issues in Urinary Incontinence in Women. Am J Obstet Gynecol 2003; 188:S77.

5. Milson I, Altman D, Lapitan, et al.. Epidemiology of urinary and faecal incontinence and pelvic organ prolapse. In: Incontinence, 4th ed., Abrams P, Cardozo L, Khoury S, Wein A (Eds), Health Publications Ltd., Plymouth, UK 2009. p.35.

6. Robinson D, Hanna-Mitchell A, Rantell A, et al. Are we justified in suggesting change to caffeine, alcohol, and carbonated drink intake in lower urinary tract disease? Report from the ICI-RS 2015. Neurourol Urodyn 2017; 36:876.

7. Coyne KS, Sexton CC, Irwin DE, et al. The impact of overactive bladder, incontinence and other lower urinary tract symptoms on quality of life, work productivity, sexuality and emotional well-being in men and women: results from the EPIC study. BJU Int 2008; 101:1388.

8. www.cms.gov/Medicare/Quality-Initiatives-Patient-Assessment-Instruments/QualityMeasures/Downloads/Eligible-Providers-2014-Proposed-EHR-Incentive-Program-CQM.pdf (Accessed on April 06, 2015).

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ÀÎõ°ú¹Î¼º¹æ±¤ ÇÑÀÇ¿ø ÁÖ¸»Áø·á""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ±Û¾²±â ¼öÁ¤ »èÁ¦
ÀÌÀü±Û û¶óÇѾà´ÙÀ̾îÆ® ÇÑÀÇ¿ø Ãʱ⿡ ÀâÀÚ
´ÙÀ½±Û õȣ¿ª ÇÏ´ÃüÇÑÀÇ¿ø 10¿ù ´Üµ¶¾ÞÄÝÀ̺¥Æ®
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
772 ±¤ÁÖ ¿Ã¹Ù¸¥ÇÑÀÇ¿ø »ó¹«Áö±¸ ´ÙÀ̾îÆ®ÇÑÀÇ¿ø ¼öÇè»ý ÇÒÀÎ À̺¥Æ® 0 1,963 2020-12-01
771 ¸®»ùÇÑÀÇ¿ø ÀÏ»êÁ¡ 2020³â 12¿ù À̺¥Æ® ¾È³» 0 1,117 2020-12-01
770 ÇØÀ²ÇÑÀÇ¿ø ÀÎõÁ¡ 12¿ù À̺¥Æ® 0 1,592 2020-12-01
769 ÀÌõ ±³Åë»ç°í ÀÔ¿ø º´¿ø ¹Ì¿ÃÇÑÀÇ¿ø ÀÔ¿ø½Ç ¾Ë·Áµå·Á¿ä 6 1,795 2020-11-28
768 ¼öÇè»ýº¸¾à, ¼öÇè»ý ´ÙÀ̾îÆ® À̺¥Æ®: ¼ö´ÉÀÇ ½ÃÀÛ°ú ³¡Àº ¼ø¸®ÇÑÀÇ¿ø.. 0 4,145 2020-11-27
767 ½º¸¶Æ®ÇÑÀÇ¿ø 12¿ù À̺¥Æ® 0 860 2020-11-25
766 ¾î±úµ¿¹«ÇÑÀÇ¿ø 11¿ù µ¿Çà À̺¥Æ® 0 1,073 2020-11-18
765 ·Î´ãÇÑÀÇ¿ø 11¿ù À̺¥Æ® 2źÀÔ´Ï´Ù 0 1,545 2020-11-12
764 [Àå¼ö´çÇÑÀÇ¿ø] ÀÌÀü°³¿ø ±â³ä À̺¥Æ® ¾È³» 0 1,731 2020-11-12
763 ÀºÇ೪¹«ÇÑÀÇ¿ø 2020³â 11¿ù ¼ö´É À̺¥Æ® 0 968 2020-11-09
762 2020³â<¾î±úµ¿¹« ÇÑÀÇ¿ø> ¼ö´É, µ¿ÇàÀ̺¥Æ® 0 1,069 2020-11-09
761 ·Î´ãÇÑÀÇ¿ø 11¿ù À̺¥Æ® ¾È³»ÀÔ´Ï´Ù 0 1,416 2020-11-09
760 ³» ¸é¿ª¼¼Æ÷ 70%°¡ Àå¿¡ ºÐÆ÷ ..º¯ºñ°¡ ¾ø¾îÁ³³×¿ä 0 709 2020-11-06
759 ±¤ÁÖ±Ô¸²ÇÑÀÇ¿ø 2020³â 11¿ù~12¿ù À̺¥Æ® ÀÔ´Ï´Ù 0 1,432 2020-11-04
758 11¿ù ÂüÇÑÀÇ¿ø ¸é¿ª·Â °­È­¿¡ ÁÁÀº °æ¿Á°í, °æ¿Áȯ ÇÒÀÎ À̺¥Æ® 0 888 2020-11-04
757 [11¿ù]¼öÇÑÀÇ¿ø ÃѸí°øÁø´Ü À̺¥Æ® 0 927 2020-11-04
756 ´Ù³ªÇÑÀÇ¿øÀÇ 11¿ù ȯÀý±â À̺¥Æ® 0 876 2020-11-04
755 ÇØÀ²ÇÑÀÇ¿ø È«´ëÁ¡ 2020³â 11¿ù °¡°Ý À̺¥Æ® ¾È³» 0 1,478 2020-11-04
754 ¿¬¸»Áغñ ±Ô¸²ÇÑÀÇ¿ø°ú ÇÔ²² Çϼ¼¿ä 0 967 2020-10-29
753 [µµºÀ°æÈñÇÑÀÇ¿ø] 10¿ù ÇÒÀÎ À̺¥Æ® 0 1,183 2020-10-12
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷